UK clears Janssen-Cilag’s drug for Crohn’s disease, ulcerative colitis
HQ Team May 19, 2025: The UK’s Medicines and Healthcare products Regulatory Agency has approved Janssen-Cilag Limited’s guselkumab (Tremfya) to treat Crohn’s disease.
Drugs
Health
Pharma
Drugs
Health
Pharma
Contineum’s test drug may reverse multiple sclerosis damage
Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.